Mesenchymal stem cells/multipotent mesenchymal stromal cells (MSCs): Potential role in healing cutaneous chronic wounds

International Journal of Lower Extremity Wounds

Volumn 11, Issue 4, 2012, Pages 244-253

  Zou, Ji Ping ^a,b,c   Huang, Sha ^c   Peng, Yan ^a,c,d   Liu, Hong Wei ^e   Cheng, Biao ^a   Fu, Xiao Bing ^c   Xiang, Xiao Fei ^a,d  

^a GUANGZHOU GENERAL HOSPITAL OF GUANGZHOU MILITARY COMMAND   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c CHINESE PLA GENERAL HOSPITAL   (China)

^d SOUTHERN MEDICAL UNIVERSITY   (China)

^e THE FIRST AFFILIATED HOSPITAL OF JINAN UNIVERSITY   (China)

Author keywords

cell therapy; chronic wounds; mechanism; mesenchymal stem cells multipotent mesenchymal stromal cells

Indexed keywords

GROWTH FACTOR;

ANGIOGENESIS; ANTIOXIDANT ACTIVITY; CELL DIFFERENTIATION; CELL FUSION; CELL THERAPY; CHRONIC WOUND; EXPERIMENTAL ANIMAL; HYPERBARIC OXYGEN; IMMUNOREGULATION; MESENCHYMAL STEM CELL; MESENCHYMAL STROMA CELL; MULTIPOTENT STEM CELL; NONHUMAN; PARACRINE SIGNALING; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SKIN INJURY; VACUUM ASSISTED CLOSURE; WOUND DRESSING; WOUND HEALING;

ANIMALS; BANDAGES; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FEMALE; GRAFT SURVIVAL; HUMANS; INJURY SEVERITY SCORE; LEG ULCER; LOWER EXTREMITY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; PROGNOSIS; RISK ASSESSMENT; SKIN; SKIN DISEASES; TREATMENT OUTCOME; WOUND HEALING;

EID: 84870827252     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734612463935     Document Type: Review

References (84)

1. Bitsch M, Laursen I, Engel AM, et al. Epidemiology of chronic wound patients and relation to serum levels of mannan-binding lectin. Acta Derm Venereol. 2009 ; 89: 607-611
2. Jiang Y, Huang S, Fu X, et al. Epidemiology of chronic cutaneous wounds in China. Wound Repair Regen. 2011 ; 19: 181-188
3. Fan WPL, Rashid M, Enoch S. Current advances in modern wound healing. Wounds UK. 2010 ; 6: 22-36
4. Summer EH. Mesenchymal stem cells: a multimodality option for wound healing. Adv Wound Care. 2012 ; 1: 153-158
5. Chagastelles PC, Nardi NB, Camassola M. Biology and applications of mesenchymal stem cells. Sci Prog. 2010 ; 93: 113-127
6. Fathke C, Wilson L, Hutter J, et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells. 2004 ; 22: 812-822 (Pubitemid 39166938)
7. Vojtassak J, Danisovic L, Kubes M, et al. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot. Neuro Endocrinol Lett. 2006 ; 27: 134-137 (Pubitemid 46534356)
8. Hanson SE, Bentz ML, Hematti P. Mesenchymal stem cell therapy for nonhealing cutaneous wounds. Plast Reconstr Surg. 2010 ; 125: 510-516
9. Boyko EJ, Ahroni JH, Stensel V, Forsberg RC, Davignon DR, Smith DG. A prospective study of risk factors for diabetic foot ulcer. the Seattle Diabetic Foot Study. Diabetes Care. 1999 ; 22: 1036-1042 (Pubitemid 29293951)
10. Mustoe T. Understanding chronic wounds: a unifying hypothesis on their pathogenesis and implications for therapy. Am J Surg. 2004 ; 187: 65-70
11. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007 ; 117: 1219-1222 (Pubitemid 46718408)
12. Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010 ; 89: 219-229
13. Bishop A. Role of oxygen in wound healing. J Wound Care. 2008 ; 17: 399-402
14. Rodriguez PG, Felix FN, Woodley DT, Shim EK. The role of oxygen in wound healing: a review of the literature. Dermatol Surg. 2008 ; 34: 1159-1169
15. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007 ; 127: 514-525
16. Ishida YKT, Takayasu T, Iwakura Y, Mukaida N. The essential involvement of cross-talk between IFN-g and TGF-b in the skin wound healing process. J Immunol. 2004 ; 172: 1848-1855 (Pubitemid 38116834)
17. Frykberg RG. Diabetic foot ulcers: pathogenesis and management. Am Fam Physician. 2002 ; 66: 1655-1662 (Pubitemid 36068123)
18. Barrick B, Campell EJ, Owen CA. Leukocyte proteinases in wound healing: roles in physiologic and pathological processes. Wound Repair Regen. 1999 ; 7: 410-422 (Pubitemid 30027563)
19. Harding KG, Morris HL, Patel GK. Science, medicine and the future: healing chronic wounds. BMJ. 2002 ; 324: 160-163 (Pubitemid 34084511)
20. Werdin F, Tenenhaus M, Rennekampff HO. Chronic wound care. Lancet. 2008 ; 372: 1860-1862
21. Dissemond J. Modern wound dressings for the therapy of chronic wounds. Hautarzt. 2006 ; 57: 881-887 (Pubitemid 44526283)
22. Pechter PM, Gil J, Valdes J, et al. Keratin dressings speed epithelialization of deep partial-thickness wounds. Wound Repair Regen. 2012 ; 20: 236-242
23. Tang L, Sierra JO, Kelly R, Kirsner RS, Li J. Wool-derived keratin stimulates human keratinocyte migration and types IV and VII collagen expression. Exp Dermatol. 2012 ; 21: 458-460
24. Sussman G, Weller C. Wound dressings update. J Pharm Pract Res. 2006 ; 36: 318-324 (Pubitemid 46166337)
25. Evans D, Land L. Topical negative pressure for treating chronic wounds: a systematic review. Br J Plast Surg. 2001 ; 54: 238-242 (Pubitemid 32288608)
26. Banwell PE, Musgrave M. Topical negative pressure therapy: mechanisms and indications. Int Wound J. 2004 ; 1: 95-106
27. Shirakawa M, Isseroff RR. Topical negative pressure devices: use for enhancement of healing chronic wounds. Arch Dermatol. 2005 ; 141: 1449-1453 (Pubitemid 41668699)
28. Armstrong DG, Lavery LA. Negative pressure wound therapy after partial diabetic foot amputation: a multicentre, randomised controlled trial. Lancet. 2005 ; 366: 1704-1710 (Pubitemid 41587449)
29. Tauro LF, Ravikrishnan J, Rao-Satish BS, Divakar-Shenoy H, Shetty SR, Menezes LT. A comparative study of the efficacy of topical negative pressure moist dressings and conventional moist dressings in chronic wounds. Indian J Plast Surg. 2007 ; 40: 133-140
30. Ubbink DT, Westerbos SJ, Nelson EA, Vermeulen H. A systematic review of topical negative pressure therapy for acute and chronic wounds. Br J Surg. 2008 ; 95: 685-692
31. Londahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care. 2010 ; 33: 998-1003
32. Roeckl-Wiedmann I, Bennett M, Kranke P. Systematic review of hyperbaric oxygen in the management of chronic wounds. Br J Surg. 2005 ; 92: 24-32 (Pubitemid 40144189)
33. Charbord P. Bone marrow mesenchymal stem cells: historical overview and concepts. Hum Gene Ther. 2010 ; 21: 1045-1056
34. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells: The International Society for Cellular Therapy position statement. Cytotherapy. 2006 ; 8: 315-317 (Pubitemid 44269669)
35. Wu Y, Zhao RC, Tredget EE. Concise review: bone marrow-derived stem/progenitor cells in cutaneous repair and regeneration. Stem Cells. 2010 ; 28: 905-915
36. Yoshikawa T, Mitsuno H, Nonaka I, et al. Wound therapy by marrow mesenchymal cell transplantation. Plast Reconstr Surg. 2008 ; 121: 860-877 (Pubitemid 351642820)
37. Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitro. Stem Cells. 2004 ; 22: 377-384 (Pubitemid 38736621)
38. Paunescu V, Deak E, Herman D, et al. In vitro differentiation of human mesenchymal stem cells to epithelial lineage. J Cell Mol Med. 2007 ; 11: 502-508 (Pubitemid 47153460)
39. Wu Y, Chen L, Scott PG, Tredget EE. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis. Stem Cells. 2007 ; 25: 2648-2659 (Pubitemid 47582758)
40. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. J Immunol. 2008 ; 108: 2581-2587
41. Deng W, Han Q, Liao L, et al. Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue. Tissue Eng. 2005 ; 11: 110-119 (Pubitemid 40515179)
42. Prockop D. "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther. 2007 ; 82: 241-243 (Pubitemid 47258475)
43. Javazon EH, Keswani SG, Badillo AT, et al. Enhanced epithelial gap closure and increased angiogenesis in wounds of diabetic mice treated with adult murine bone marrow stromal progenitor cells. Wound Repair Regen. 2007 ; 15: 350-359 (Pubitemid 46817411)
44. Semedo P, Burgos-Silva M, Donizetti-Oliveira C. How do mesenchymal stem cells repair?. Stem Cells. 2010 ; 4: 83-104
45. Galiano RD, Tepper OM, Pelo CR, et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol. 2004 ; 164: 1935-1947 (Pubitemid 38669343)
46. Zentilin L, Tafuro S, Zacchigna S, et al. Bone marrow mononuclear cells are recruited to the sites of VEGF-induced neovascularization but are not incorporated into the newly formed vessels. Blood. 2006 ; 107: 3546-3554
47. Chao-Fei L, Yan L. Progress of research on mechanisms of vascular maturation. Chin J Inj Repair Wound Healing. 2011 ; 6: 279-284
48. Murakami M, Nguyen LT, Zhuang ZW, et al. The FGF system has a key role in regulating vascular integrity. J Clin Invest. 2008 ; 118: 3355-3366
49. Tu-Lai Y, Yeh-Ting H, Hsin-Yang L, et al. Enhancement of wound healing by human multipotent stromal cell conditioned medium: the paracrine factors and p38 MAPK activation. Cell Transplant. 2011 ; 20: 693-706
50. Kamihata H, Matsubara H, Nishiue T, et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation. 2001 ; 104: 1046-1052 (Pubitemid 32803883)
51. Caplan AI. What's in a name?. Tissue Eng Part A. 2010 ; 16: 2415-2417
52. Cutler AJ, Limbani V, Girdlestone J, Navarrete CV. Umbilical cord-derived mesenchymal stromal cells modulate monocyte function to suppress T cell proliferation. J Immunol. 2010 ; 185: 6617-6623
53. Djouad F, Charbonnier L-M, Bouffi C, et al. Mesenchymal stem cells inhibit the differentiation of dendritic cells through an interleukin-6- dependent mechanism. Stem Cells. 2007 ; 25: 2025-2032 (Pubitemid 47258180)
54. Nemeth K, Leelahavanichkul A, Yuen PST, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E2-dependent reprogramming of host macrophages to increase their interleukin- 10 production. Nat Med. 2008 ; 15: 42-49
55. Selmani Z, Naji A, Zidi I, et al. Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+CD25highFOXP3+ regulatory T cells. Stem Cells. 2008 ; 26: 212-222
56. Traggiai E, Volpi S, Schena F, et al. Bone marrow-derived mesenchymal stem cells induce both polyclonal expansion and differentiation of B cells isolated from healthy donors and systemic lupus erythematosus patients. Stem Cells. 2008 ; 26: 562-569 (Pubitemid 351413617)
57. Zhang QZ, Su WR, Shi SH, et al. Human gingiva-derived mesenchymal stem cells elicit polarization of m2 macrophages and enhance cutaneous wound healing. Stem Cells. 2010 ; 28: 1856-1868
58. Tu Z, Li Q, Bu H, Lin F. Mesenchymal stem cells inhibit complement activation by secreting factor H. Stem Cells Dev. 2010 ; 19: 1803-1809
59. Park M-J, Shin J-S, Kim Y-H, et al. Murine mesenchymal stem cells suppress T lymphocyte activation through IL-2 receptor α(CD25) cleavage by producing matrix metalloproteinases. Stem Cell Rev. 2011 ; 7: 381-393
60. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008 ; 8: 726-736
61. Morandi F, Raffaghello L, Bianchi G, et al. Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T-cell responses against viral or tumor-associated antigens. Stem Cells. 2008 ; 26: 1275-1287
62. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005 ; 105: 1815-1822 (Pubitemid 40223708)
63. Krampera M, Cosmi L, Angeli R, et al. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells. Stem Cells. 2006 ; 24: 386-398 (Pubitemid 44464808)
64. Ryan JM, Barry F, Murphy JM, Mahon BP. Interferon-γ does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cells. Clin Exp Immunol. 2007 ; 149: 353-363 (Pubitemid 47063057)
65. Spaggiari GM, Capobianco A, Abdelrazik H, Becchetti F, Mingari MC, Moretta L. Mesenchymal stem cells inhibit natural killer-cell proliferation, cytotoxicity, and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2. Blood. 2008 ; 111: 1327-1333 (Pubitemid 351213419)
66. Ren G, Zhang L, Zhao X, et al. Mesenchymal stem cell-mediated immunosuppression occurs via concerted action of chemokines and nitric oxide. Cell Stem Cell. 2008 ; 2: 141-150 (Pubitemid 351181031)
67. Kitaori T, Ito H, Schwarz EM, et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. Arthritis Rheum. 2009 ; 60: 813-823
68. Villaron E, Almeida J, Lopez-Holgado N, et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica. 2004 ; 89: 1421-1427 (Pubitemid 39643507)
69. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004 ; 10: 858-864 (Pubitemid 39070860)
70. Hui L, Hong Y, Jingjing Z, Yuan H, Qi C, Nong Z. HGF suppresses high glucose-mediated oxidative stress in mesangial cells by activation of PKG and inhibition of PKA. Free Radic Biol Med. 2010 ; 49: 467-473
71. Kortesidis A, Zannettino A, Isenmann S, Shi S, Lapidot T, Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood. 2005 ; 105: 3793-3801 (Pubitemid 40656121)
72. Li L, Jiang J. Regulatory factors of mesenchymal stem cell migration into injured tissues and their signal transduction mechanisms. Front Med. 2011 ; 5: 33-39
73. Kim W-S, Park B-S, Sung J-H. The wound-healing and antioxidant effects of adipose-derived stem cells. Expert Opin Biol Ther. 2009 ; 9: 879-887
74. Kim WS, Park BS, Kim HK, et al. Evidence supporting antioxidant action of adipose-derived stem cells: protection of human dermal fibroblasts from oxidative stress. J Dermatol Sci. 2008 ; 49: 133-142
75. Kemp K, Gordon D, Wraith DC, et al. Fusion between human mesenchymal stem cells and rodent cerebellar Purkinje cells. Neuropathol Appl Neurobiol. 2011 ; 37: 166-178
76. Prockop DJ, Gregory CA, Spees JL. One strategy for cell and gene therapy: harnessing the power of adult stem cells to repair tissues. Proc Natl Acad Sci U S A. 2003 ; 100: 11917-11923 (Pubitemid 37205904)
77. Gang Z, Xiao-Bing F, Tong-Zhu S. Genes expression profie in the co-culture of human bone marrow mesenchymal stem cells with sweat glands cells and the implication. Chin J Exp Surg. 2007 ; 24: 1186-1188
78. Inal JM, Ansa-Addo EA, Stratton D, et al. Microvesicles in health and disease. Arch Immunol Ther Exp (Warsz). 2012 ; 60: 107-121
79. Hugel B, Martinez MC, Kunzelmann C, Freyssinet JM. Membrane microparticles: two sides of the coin. Physiology (Bethesda). 2005 ; 20: 22-27 (Pubitemid 40363367)
80. Tetta C, Bruno S, Fonsato V, Deregibus MC, Camussi G. The role of microvesicles in tissue repair. Organogenesis. 2011 ; 7: 105-115
81. Falanga V, Iwamoto S, Chartier M, et al. Autologous bone marrow-derived cultured mesenchymal stem cells delivered in a fibrin spray accelerate healing in murine and human cutaneous wounds. Tissue Eng. 2007 ; 13: 1299-1312 (Pubitemid 46986730)
82. Piao W, Wang H, Inoue M, Hasegawa M, Hamada H, Huang J. Transplantation of Sendai viral angiopoietin-1-modified mesenchymal stem cells for ischemic limb disease. Angiogenesis. 2010 ; 13: 203-210
83. Gauglitz GG, Jeschke MG. Combined gene and stem cell therapy for cutaneous wound healing. Mol Pharm. 2011 ; 8: 1471-1479
84. Izadpanah R, Bunnell BA. Gene delivery to mesenchymal stem cells. Methods Mol Biol. 2008 ; 449: 153-167